427 related articles for article (PubMed ID: 24410633)
1. ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.
Salvatore MF
J Neurochem; 2014 May; 129(3):548-58. PubMed ID: 24410633
[TBL] [Abstract][Full Text] [Related]
2. Prolonged increase in ser31 tyrosine hydroxylase phosphorylation in substantia nigra following cessation of chronic methamphetamine.
Salvatore MF; Nejtek VA; Khoshbouei H
Neurotoxicology; 2018 Jul; 67():121-128. PubMed ID: 29782882
[TBL] [Abstract][Full Text] [Related]
3. Nigral-specific increase in ser31 phosphorylation compensates for tyrosine hydroxylase protein and nigrostriatal neuron loss: Implications for delaying parkinsonian signs.
Kasanga EA; Han Y; Shifflet MK; Navarrete W; McManus R; Parry C; Barahona A; Nejtek VA; Manfredsson FP; Kordower JH; Richardson JR; Salvatore MF
Exp Neurol; 2023 Oct; 368():114509. PubMed ID: 37634696
[TBL] [Abstract][Full Text] [Related]
4. Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generation.
Salvatore MF; Pruett BS; Spann SL; Dempsey C
PLoS One; 2009 Dec; 4(12):e8466. PubMed ID: 20037632
[TBL] [Abstract][Full Text] [Related]
5. GFR-α1 Expression in Substantia Nigra Increases Bilaterally Following Unilateral Striatal GDNF in Aged Rats and Attenuates Nigral Tyrosine Hydroxylase Loss Following 6-OHDA Nigrostriatal Lesion.
Kasanga EA; Owens CL; Cantu MA; Richard AD; Davis RW; McDivitt LM; Blancher B; Pruett BS; Tan C; Gajewski A; Manfredsson FP; Nejtek VA; Salvatore MF
ACS Chem Neurosci; 2019 Oct; 10(10):4237-4249. PubMed ID: 31538765
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of RET and GDNF family receptor, GFR-α1, between striatum and substantia nigra following nigrostriatal lesion: A case for diminished GDNF-signaling.
Kasanga EA; Han Y; Navarrete W; McManus R; Shifflet MK; Parry C; Barahona A; Manfredsson FP; Nejtek VA; Richardson JR; Salvatore MF
Exp Neurol; 2023 Aug; 366():114435. PubMed ID: 37178997
[TBL] [Abstract][Full Text] [Related]
7. Dichotomy of tyrosine hydroxylase and dopamine regulation between somatodendritic and terminal field areas of nigrostriatal and mesoaccumbens pathways.
Salvatore MF; Pruett BS
PLoS One; 2012; 7(1):e29867. PubMed ID: 22242182
[TBL] [Abstract][Full Text] [Related]
8. Altered melatonin MT
Kang NH; Carriere CH; Bahna SG; Niles LP
Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
[TBL] [Abstract][Full Text] [Related]
9. Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity.
Pruett BS; Salvatore MF
Mol Neurobiol; 2013 Jun; 47(3):988-99. PubMed ID: 23321789
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.
Salvatore MF; Calipari ES; Jones SR
ACS Chem Neurosci; 2016 Jul; 7(7):941-51. PubMed ID: 27124386
[TBL] [Abstract][Full Text] [Related]
11. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
13. Alterations in tyrosine hydroxylase expression following partial lesions of the nigrostriatal bundle.
Sherman TG; Moody CA
Brain Res Mol Brain Res; 1995 Apr; 29(2):285-96. PubMed ID: 7609616
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
Matsuura K; Makino H; Ogawa N
Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
[TBL] [Abstract][Full Text] [Related]
15. Nasal application of kisspeptin-54 mitigates motor deficits by reducing nigrostriatal dopamine loss in hemiparkinsonian rats.
Sinen O; Sinen AG; Derin N; Aslan MA
Behav Brain Res; 2024 Jun; 468():115035. PubMed ID: 38703793
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat.
Kozlowski DA; Miljan EA; Bremer EG; Harrod CG; Gerin C; Connor B; George D; Larson B; Bohn MC
Brain Res; 2004 Aug; 1016(2):170-81. PubMed ID: 15246853
[TBL] [Abstract][Full Text] [Related]
17. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA
J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683
[TBL] [Abstract][Full Text] [Related]
18. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
Rosenblad C; Kirik D; Björklund A
Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
[TBL] [Abstract][Full Text] [Related]
19. Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system.
Salvatore MF; Gerhardt GA; Dayton RD; Klein RL; Stanford JA
Exp Neurol; 2009 Sep; 219(1):197-207. PubMed ID: 19460370
[TBL] [Abstract][Full Text] [Related]
20. The effects of nigrostriatal dopamine depletion on the thalamic parafascicular nucleus.
Kusnoor SV; Bubser M; Deutch AY
Brain Res; 2012 Mar; 1446():46-55. PubMed ID: 22353754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
